Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
The Journal of Pain
|
April 5, 2011
Efficacy of low-dose celecoxib in patients with acute pain
Bernard P Schachtel, Dorothy McCabe, Manuela Berger, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 15, 2016
Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose-response analysis
Daniela J Conrado, Sriram Krishnaswami, Satoshi Shoji, et al.
RMD Open
|
June 7, 2019
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
Frank Buttgereit, Vibeke Strand, Eun Bong Lee, et al.
Arthritis and Rheumatism
|
March 29, 2002
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
Stanley Cohen, Eric Hurd, John Cush, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
The Journal of Pain
|
April 5, 2011
Efficacy of low-dose celecoxib in patients with acute pain
Bernard P Schachtel, Dorothy McCabe, Manuela Berger, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 15, 2016
Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose-response analysis
Daniela J Conrado, Sriram Krishnaswami, Satoshi Shoji, et al.
RMD Open
|
June 7, 2019
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
Frank Buttgereit, Vibeke Strand, Eun Bong Lee, et al.
Arthritis and Rheumatism
|
March 29, 2002
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
Stanley Cohen, Eric Hurd, John Cush, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Page
of 2